Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease

被引:28
|
作者
Beres, Nra Judit [1 ]
Kiss, Zoltan [1 ]
Sztupinszki, Zsofia [1 ]
Lendvai, Gabor [2 ]
Arato, Andras [1 ]
Sziksz, Erna [1 ,3 ]
Vannay, Adam [1 ,3 ]
Szabo, Attila J. [1 ,3 ]
Muller, Katalin Eszter [1 ]
Cseh, Aron [1 ]
Boros, Kriszta [1 ]
Veres, Gabor [1 ,3 ]
机构
[1] Semmelweis Univ, Dept Pediat 1, Bokay Janos Str 53-54, H-1083 Budapest, Hungary
[2] MTA SE Tumor Progress Res Grp, Budapest, Hungary
[3] MTA SE Pediat & Nephrol Res Grp, Budapest, Hungary
基金
匈牙利科学研究基金会;
关键词
Inflammatory bowel disease; MicroRNA; Mucosal; Pediatric; CROHNS-DISEASE; COLONIC-MUCOSA; ADOLESCENT PATIENTS; ULCERATIVE-COLITIS; 5-YEAR ANALYSES; CANCER CELLS; CHILDREN; PATHOGENESIS; RESISTANCE; BIOMARKERS;
D O I
10.1016/j.dld.2016.12.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: MicroRNAs (miRs) came recently into focus as promising novel research targets offering new insights into the pathogenesis of inflammatory bowel diseases (IBD). Aims: The aim of our study was to identify a pediatric IBD (pIBD) characteristic miR profile serving as potential Crohn's disease (CD) and ulcerative colitis (UC) specific diagnostic pattern and to further analyze the related target genes. Methods: Small RNA sequencing was performed on inflamed and intact colonic biopsies of CD, and control patients. Selected miRs were further investigated by RT-PCR, complemented with an UC group, in order to address the differential diagnostic potential of miRs in the two IBD subtypes. To analyze network connection of differentially expressed miRs and their target genes MiRTarBase database and previous transcriptome sequencing data from pediatric patient groups were used. Results: Sequencing analysis identified 170 miRs with altered expression. RT-PCR analysis revealed altered expression of miR-31, -125a, -142-3p, and -146a discriminating between the inflamed mucosa of CD and UC. In the intact mucosa of CD patients the expression of miR-18a, -20a, -21, -31, -99a, -99b, -100, -125a, -126, -142-5p, -146a, -185, -204, -221, and -223 was elevated compared to the controls. The expression of miR-20a, -204 and -221 was elevated exclusively in the intact region of CD patients compared to the controls. Enrichment analysis identified main IBD-related functional groups. Conclusions: We demonstrated a characteristic colonic miR pattern in pIBD that could facilitate deeper understanding of the pathomechanism of IBD and may serve as a diagnostic tool. (C) 2016 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
引用
收藏
页码:378 / 387
页数:10
相关论文
共 50 条
  • [31] The Impact of Infliximab Therapy On Colonic Mucosal Expression of Barrier Genes in Patients with Inflammatory Bowel Disease
    Arijs, Ingrid
    Quintens, Roel
    Van Lommel, Leentje
    Van Steen, Kristel
    De Hertogh, Gert
    Van Assche, Gert A.
    Vermeire, Severine
    Geboes, Karel
    Schuit, Frans C.
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2009, 136 (05) : A210 - A210
  • [32] Mucosal Healing in Inflammatory Bowel Disease
    Osterman, Mark T.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 212 - 221
  • [33] Mucosal flora in inflammatory bowel disease
    Swidsinski, A
    Ladhoff, A
    Pernthaler, A
    Swidsinski, S
    Loening-Baucke, V
    Ortner, M
    Weber, J
    Hoffmann, U
    Schreiber, S
    Dietel, M
    Lochs, H
    GASTROENTEROLOGY, 2002, 122 (01) : 44 - 54
  • [34] Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease
    Beres, Nora J.
    Szabo, Doloresz
    Kocsis, Dorottya
    Szucs, Daniel
    Kiss, Zoltan
    Mueller, Katalin E.
    Lendvai, Gabor
    Kiss, Andras
    Arato, Andras
    Sziksz, Erna
    Vannay, Adam
    Szabo, Attila J.
    Veres, Gabor
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (02) : 327 - 335
  • [35] Global gene expression in colonic biopsies from pediatric inflammatory bowel disease patients
    McCahan, SM
    Proujansky, R
    PEDIATRIC RESEARCH, 2002, 51 (04) : 145A - 145A
  • [36] Ultrasonographic imaging of inflammatory bowel disease in pediatric patients
    Chiorean, Liliana
    Schreiber-Dietrich, Dagmar
    Braden, Barbara
    Cui, Xin-Wu
    Buchhorn, Reiner
    Chang, Jian-Min
    Dietrich, Christoph F.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) : 5231 - 5241
  • [37] Eosinophilic esophagitis in pediatric patients with inflammatory bowel disease
    Doherty, T.
    Dohil, R.
    Bastian, J.
    Newbury, R.
    Aceves, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A70 - A70
  • [38] Disaccharidase Deficiency in Pediatric Patients with Inflammatory Bowel Disease
    Friesen, Chance S.
    San Pablo, William
    Bass, Julie
    Garg, Uttam
    Colombo, Jennifer M.
    GASTROINTESTINAL DISORDERS, 2022, 4 (01): : 1 - 7
  • [39] Use of rifaximin in pediatric patients with inflammatory bowel disease
    Muniyappa, Pramodha
    Gulati, Reema
    Vera, Hupertz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S551 - S551
  • [40] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72